Abstract
The big Belgian chemical maker Solvay has formed a partnership with the US synthetic biology firm Ginkgo Bioworks in a bid to develop more biobased products. As part of the agreement, Solvay will acquire a lab in Cambridge, Massachusetts, that Ginkgo got in 2022 as part of its $300 million purchase of Zymergen . The partnership’s initial focus will be on developing biopolymers and specialty chemicals for markets including home and personal care, agriculture, and food. Solvay is seeking to develop biomaterials for both existing and new markets, CEO Ilham Kadri says in a press release . “Biotech is the future and this step is an important milestone for our growth platform,” she says. Biobased products that Solvay already produces include a natural alternative to synthetic vanillin, a polymer sourced from guar seeds, and rice-husk-derived silica for tires . Ginkgo’s core capability is the programming of cells to make food,
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
